A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study.
作者:
主题词
青少年(Adolescent);成年人(Adult);抗代谢药, 抗肿瘤(Antimetabolites, Antineoplastic);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);阿糖胞苷(Cytarabine);剂量效应关系, 药物(Dose-Response Relationship, Drug);人类(Humans);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);白细胞计数(Leukocyte Count);中年人(Middle Aged);缓解诱导(Remission Induction);存活率分析(Survival Analysis);治疗结果(Treatment Outcome);青年人(Young Adult)
DOI
10.1182/blood-2010-07-295279
PMID
21190996
发布时间
2022-04-19
- 浏览31

Blood
2366-72页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文